Impact of Environmental Factors on Disease Activity in Spondyloarthritis (SPA): Results of the Prospective Co-Env Cohort

Spondylarthritis Clinical Trial

— CoEnv  

Official title:

Impact of Environmental Factors on Disease Activity in Spondyloarthritis (SPA): Results of the Prospective Co-Env Cohort

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01314547
• Other study ID #: AOM02020
• Status: Completed
• Phase: N/A
• First received: March 11, 2011
• Last updated: October 12, 2012
• Start date: March 2005
• Est. completion date: December 2011

Study information

• Verified date: November 2010
• Source: Assistance Publique - Hôpitaux de Paris
• Contact: n/a
• Is FDA regulated: No
• Health authority: France: Ministry of Health
• Study type: Observational

Clinical Trial Summary

Susceptibility to SPA has been shown to be largely genetically determined. The objective of this study was to prospectively investigate the impact of several environmental factors on disease activity.

Description:

Susceptibility to SPA has been shown to be largely genetically determined but the contribution of environmental factors to disease evolution has not yet been elucidated. The objective of this study was to prospectively investigate the impact of several environmental factors on disease activity.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 300
• Est. completion date: December 2011
• Est. primary completion date: December 2011
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• 18 years SPONDILARTHRITIS: modified New York criteria Systemic vasculitis: ACR criteria

Exclusion Criteria:

no internet access

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Primary Systemic Vasculitis
• Spondylarthritis
• Systemic Vasculitis
• Vasculitis

Locations

Country	Name	City	State
France	hopital ambroise Pare	Boulogne

Sponsors (1)

Lead Sponsor	Collaborator
Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Score on a disease activity rating scale	Score on a disease activity rating scale (quaterly,than monthly basis)	Six years	No
Secondary	Ancillary studies will be possible with the available database	Ancillary studies will be possible with the available database	six years	No